New transplant approach opens donor options for blood cancer patients
NCT ID NCT01203722
First seen Feb 19, 2026 · Last updated May 15, 2026 · Updated 12 times
Summary
This study tested a bone marrow transplant using donors who are not perfectly matched or first-degree relatives, for people with blood cancers. The goal was to see if this approach could control the cancer with acceptable side effects like graft-versus-host disease. 87 participants received a reduced-intensity transplant along with drugs to prevent complications. The study aimed to find a safe way to expand donor options for those who lack a perfect match.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, 21231-2410, United States
Conditions
Explore the condition pages connected to this study.